Monitoring CML Treatment: Addressing the Issues for the Community Hematologist/Oncologist
Monitoring CML Treatment: Addressing the Issues for the Community Hematologist/Oncologist Hagop M. Kantarjian, MD Chairman; Professor, Department of Leukemia.
